Track topics on Twitter Track topics that are important to you
CNS disease specialist EIP Pharma has raised $20.5 million in a series B financing round led by Access…
Original Article: BRIEF—$20.5 million for EIP Pharma to develop Alzheimer's candidateNEXT ARTICLE
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...